X

Advik Laboratories Ltd. Stock Analysis

Small Cap
Evaluated by 161 users | BSE: 531686 | NSE: |
Pharmaceuticals & Drugs
Advik Laboratories has been set up by V K Jain, a qualified production chemist with over 20 years experience in pharmaceutical products. Advik Laboratories was established in the 1994. It is WHO-GMP certified company that has been set up from the ground level with the avowed objective of...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Capital Employed 1.99%0.69%3.16%6.31%4.9%0.29%-4.3%-33.65%-4.84%-7.48%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 18.822.119.933.930.312.21.42.84.10.8
Y-o-Y Gr. Rt.-17.8%-10.1%70.5%-10.6%-59.6%-89%110.4%44%-79.7%
Adjusted EPS (Rs.) 0.06-0.4500.530.31-0.45-0.62-3.87-0.45-0.65
Y-o-Y Gr. Rt.--850%NANA-41.5%-245.2%NANANANA
Book Value per Share (Rs.) 11.9311.4811.4812.0211.5610.719.936.075.634.99
Adjusted Net Profit 0.1-0.400.50.5-0.7-1.2-7.4-0.9-1.3
Net Op. Cash Flow (Rs. Cr.) 0.30.4-1.604.62.21.30.4-0.30.6
Debt to Cash Flow from Ops 21.0122.99-7.13577.471.783.595.3117.87-19.4810.29
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Advik Laboratories Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales -29.3%-51.3%-15%-79.7%
Adjusted EPS -230.3%-216%NANA
Book Value per Share -9.2-15.5-20.5-11.4
Share Price -23.7% -46.5% -56.3% -40.7%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Equity (%) 0.5-3.850.034.552.96-3.44-6.23-48.3-7.74-12.28
Operating Profit Margin (%) 0.680.276.568.059.366.63-36.36-241.98-12.83-86.78
Net Profit Margin (%) 0.3-1.90.011.481.53-5.52-87.85-259.83-21.14-150.47
Debt to Equity 0.50.821.071.210.470.480.350.570.620.66
Working Capital Days 2622122421702255324,1131,3006212,611
Cash Conversion Cycle 1431211581221363363,2091,0174131,651
Entity Percentage Holding
Promoters 35.89%
Non-Institutions 64.11%
Pledged *55.1255.1255.1255.1271.1671.1671.1671.1671.1671.16
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Advik Laboratories Ltd.'s performance infers:

Advik Laboratories Ltd. earnings have declined by -216%, whereas share price has depreciated -46.5% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Advik Laboratories Ltd. share prices over the last 10 years. Here is what we found out:

Advik Laboratories Ltd. share price has depreciated -22.4% annually over the past ten years.

Advik Laboratories has been set up by V K Jain, a qualified production chemist with over 20 years experience in pharmaceutical products.

Advik Laboratories was established in the 1994. It is WHO-GMP certified company that has been set up from the ground level with the avowed objective of achieving USFDA standards of quality.

The company has a technical collaboration with PFC Pharma Focus of Switzerland. It enjoys leadership status at various fronts such as high product quality, a

Advik Laboratories has been set up by V K Jain, a qualified production chemist with over 20 years experience in pharmaceutical products.

Advik Laboratories was established in the 1994. It is WHO-GMP certified company that has been set up from the ground level with the avowed objective of achieving USFDA standards of quality.

The company has a technical collaboration with PFC Pharma Focus of Switzerland. It enjoys leadership status at various fronts such as high product quality, a growing range of products, state of the art manufacturing process, competitive pricing and customer service. In addition the company exports a wide range of drugs to the Middle East, South America and Africa.

The product range includes ethical, generic drugs and over the counter drugs (OTC) in various formulations.

With over 60,000 square feet of built-up area, ample developed open space around it, a state-of-the-art manufacturing facility, the ground floor has provisions for the production and in-process control section for the manufacturing of steroidal & non-steroidal formulations, change room for gents & ladies and stores for raw & packing materials. The first floor has provision for the production and in-process control section for the manufacturing of ampicillin and non-ampicillin capsules and dry syrup preparations. The second floor has provision for quality control and about 12000 sq ft area is presently being reserved for the manufacture of injectables & ointments in the second phase.

Advik Laboratories provides pharmaceutical formulations that match the international standards of quality. The facility manufactures a wide range of pharmaceuticals formulations in tablets, capsules and dry syrups.

Products - Under Ethical products, the company manufactures Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin and Chewfe-C.

Under generic products, the company manufactures drugs catering segment such as antibacterials, antiallergics, antifungals, analgesic, antipyretic and anti-inflammatory, anti-hypertensives, anthelminthics, anti-malarials, corticosteroids, erectile dysfunction, gastrointestinal agents and sedatives.

Award - Advik Laboratories has received the prestigious Udyog Patra Award from the Government of India in 1999.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback